Researchers developed a chip-based platform, “μPharma,” that rapidly predicts drug response through AI analysis for children with T-ALL, potentially enabling clinicians to make faster, personalized treatment decisions.
Utah’s $33 million investment fuels AI, advanced computing, and secure data innovation—strengthening health research and discovery statewide through leadership at the University of Utah and Huntsman Cancer Institute.
Proposed $50 million, 5-year deal with HPE would enlarge the U's computing power 3.5-fold using NVIDIA chips, driving new discoveries and innovation in cancer care and beyond.
Despite being proven to prevent six types of cancers, HPV vaccination rates remain low. An AI chatbot could help parents and caregivers better navigate HPV vaccination decisions.
Huntsman Cancer Institute brought together top researchers from across the country to address how artificial intelligence and other technologies will innovate cancer prevention and care delivery—particularly for rural patients.
Aik Choon Tan, PhD, senior director of data science, explains how Huntsman Cancer Institute is utilizing artificial intelligence to accelerate discoveries and improve patient care.
Breast cancer imaging expert Matthew Covington, MD, and radiologist at Huntsman Cancer Institute, shares his knowledge of using artificial intelligence to better diagnose and treat breast cancer.
Chatbots and artificial intelligence are increasingly becoming more popular to answer questions about health. Researchers studied one of these resources, ChatGPT, to provide incredibly valuable and well-timed insights into the...
Read how researchers discovered genetic markers that hinder pancreatic cancer treatment and mutations that increase sarcoma risk. Then learn how artificial intelligence is helping predict prostate cancer outcomes and see...
